Regeneron Pharmaceuticals Inc (REGN) — Cash Flow Reinvestment Rate
Regeneron Pharmaceuticals Inc (REGN) has a Cash Flow Reinvestment Rate of 0.76x as of June 2026, reinvesting $438.70 Million (capex $240.20 Million plus investments $198.50 Million) from operating cash flow of $574.50 Million. See REGN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Regeneron Pharmaceuticals Inc Cash Flow Reinvestment Rate (2006–2025)
Historical reinvestment intensity for Regeneron Pharmaceuticals Inc across 16 annual periods. For the full cash flow conversion analysis, see REGN cash flow metrics.
Annual Cash Flow Reinvestment Rate for Regeneron Pharmaceuticals Inc (2006–2025)
Year-by-year capital reinvestment analysis for Regeneron Pharmaceuticals Inc. See REGN financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.30x | $1.49 Billion | $4.98 Billion | $898.40 Million | ▼ -59.1% |
| 2024 | 0.73x | $3.22 Billion | $4.42 Billion | $755.90 Million | ▼ -43.2% |
| 2023 | 1.28x | $5.90 Billion | $4.59 Billion | $926.40 Million | ▲ +154.9% |
| 2022 | 0.50x | $2.53 Billion | $5.01 Billion | $590.10 Million | ▼ -33.7% |
| 2021 | 0.76x | $5.38 Billion | $7.08 Billion | $551.90 Million | ▲ +71.8% |
| 2020 | 0.44x | $1.16 Billion | $2.62 Billion | $614.60 Million | ▼ -47.0% |
| 2019 | 0.83x | $2.03 Billion | $2.43 Billion | $429.60 Million | ▲ +26.1% |
| 2018 | 0.66x | $1.45 Billion | $2.20 Billion | $383.10 Million | ▼ -13.9% |
| 2017 | 0.77x | $1.01 Billion | $1.31 Billion | $272.60 Million | ▲ +9.2% |
| 2016 | 0.70x | $1.05 Billion | $1.49 Billion | $511.90 Million | ▲ +3.3% |
| 2015 | 0.68x | $907.60 Million | $1.33 Billion | $677.93 Million | ▲ +22.0% |
| 2014 | 0.56x | $420.78 Million | $752.43 Million | $333.01 Million | ▼ -7.4% |
| 2013 | 0.60x | $355.45 Million | $588.60 Million | $156.32 Million | ▼ -86.4% |
| 2010 | 4.44x | $428.21 Million | $96.34 Million | $99.69 Million | ▲ +559.5% |
| 2007 | 0.67x | $18.45 Million | $27.37 Million | $18.45 Million | ▲ +453.2% |
| 2006 | 0.12x | $2.81 Million | $23.07 Million | $2.81 Million | — |